Corebridge Financial’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,075
Closed -$37.8K 505
2025
Q1
$37.8K Buy
2,075
+10
+0.5% +$286 ﹤0.01% 2796
2024
Q4
$76.6K Sell
2,065
-109
-5% -$4.17K ﹤0.01% 2678
2024
Q3
$69.6K Buy
2,174
+14
+0.6% +$777 ﹤0.01% 2768
2024
Q2
$177K Buy
+2,160
New +$234K ﹤0.01% 2261

Other funds holding CDLX

Corebridge Financial's CDLX Position: Q2 2025 in Review

Corebridge Financial sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 2,075 shares — an estimated $37.8K sold.

Corebridge Financial first reported a position in CDLX in Q2 2024 and held it in 4 quarters. The position peaked at $177K in Q2 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Corebridge Financial reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 2,075 Cardlytics shares in Q2 2025, an estimated $37.8K.
  • Corebridge Financial first reported a position in Cardlytics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Cardlytics position peaked at $177K in Q2 2024.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.